NDC 0067-2035

Excedrin Migraine Geltabs

Acetaminophen, Asprin, Caffeine

Excedrin Migraine Geltabs is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Acetaminophen; Aspirin; Caffeine.

Product ID0067-2035_edbb64b9-f8ba-48db-8a36-d5837114f822
NDC0067-2035
Product TypeHuman Otc Drug
Proprietary NameExcedrin Migraine Geltabs
Generic NameAcetaminophen, Asprin, Caffeine
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2011-09-13
Marketing CategoryNDA / NDA
Application NumberNDA020802
Labeler NameGlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Substance NameACETAMINOPHEN; ASPIRIN; CAFFEINE
Active Ingredient Strength250 mg/1; mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0067-2035-20

1 BOTTLE in 1 CARTON (0067-2035-20) > 20 TABLET, COATED in 1 BOTTLE
Marketing Start Date2011-09-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0067-2035-50 [00067203550]

Excedrin Migraine Geltabs TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020802
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-09-13
Marketing End Date2014-12-31

NDC 0067-2035-80 [00067203580]

Excedrin Migraine Geltabs TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020802
Product TypeHUMAN OTC DRUG
Marketing Start Date2011-09-13

NDC 0067-2035-24 [00067203524]

Excedrin Migraine Geltabs TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020802
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-09-13
Marketing End Date2014-12-31

NDC 0067-2035-16 [00067203516]

Excedrin Migraine Geltabs TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020802
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-09-13
Marketing End Date2014-12-31

NDC 0067-2035-91 [00067203591]

Excedrin Migraine Geltabs TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020802
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-09-13
Marketing End Date2014-12-31

NDC 0067-2035-20 [00067203520]

Excedrin Migraine Geltabs TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020802
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-09-13

Drug Details

Active Ingredients

IngredientStrength
ACETAMINOPHEN250 mg/1

OpenFDA Data

SPL SET ID:cc2f4a6f-2a27-4a60-b5ef-ae0bb0988ff8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 308297
  • 209468
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • NDC Crossover Matching brand name "Excedrin Migraine Geltabs" or generic name "Acetaminophen, Asprin, Caffeine"

    NDCBrand NameGeneric Name
    0067-2021ExcedrinAcetaminophen, Asprin, Caffeine
    0067-2035ExcedrinAcetaminophen, Asprin, Caffeine

    Trademark Results [Excedrin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EXCEDRIN
    EXCEDRIN
    98594008 not registered Live/Pending
    Haleon CH SARL
    2024-06-10
    EXCEDRIN
    EXCEDRIN
    97425413 not registered Live/Pending
    GSK Consumer Healthcare SARL
    2022-05-24
    EXCEDRIN
    EXCEDRIN
    97210682 not registered Live/Pending
    GSK Consumer Healthcare SARL
    2022-01-10
    EXCEDRIN
    EXCEDRIN
    97210676 not registered Live/Pending
    GSK Consumer Healthcare SARL
    2022-01-10
    EXCEDRIN
    EXCEDRIN
    86434099 4978864 Live/Registered
    GSK CONSUMER HEALTHCARE S.A.
    2014-10-24
    EXCEDRIN
    EXCEDRIN
    85243455 3985911 Live/Registered
    GSK CONSUMER HEALTHCARE S.A.
    2011-02-16
    EXCEDRIN
    EXCEDRIN
    74504161 1892912 Dead/Cancelled
    Bristol-Myers Squibb Company
    1994-03-23
    EXCEDRIN
    EXCEDRIN
    73661685 1472811 Dead/Cancelled
    BRISTOL-MYERS COMPANY
    1987-05-18
    EXCEDRIN
    EXCEDRIN
    72080162 0696323 Dead/Cancelled
    BRISTOL-MYERS COMPANY
    1959-08-25

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.